FINWIRES · TerminalLIVE
FINWIRES

Thiogenesis Therapeutics to Raise $8 Million Via a Non-Brokered Private Placement

By

Thiogenesis Therapeutics (TTI.V) on Monday said it will raise up to $8 million in a non-brokered private placement of shares.

The company will place up to 16-million shares priced at $0.50 apiece.

The company expects to close the offering by the end of May subject to receipt of all necessary regulatory approvals.

Proceeds will be used to support the clinical development of TTI-0102, including an investigator-initiated study in cystinosis and a Phase 2 clinical study in Leigh syndrome, together with formulation and manufacturing activities, regulatory engagement, and general working capital and corporate needs.

The company's shares last traded May 8, closing at $0.56 on the TSX Venture Exchange.

Related Articles

Mining & Metals

Trisura Group Price Target Raised to $60.00 at RBC

RBC Capital Markets raised its price target on the shares of Trisura Group (TSU.TO) shares by $1.00 to $60.00 after the company's first-quarter results that were slightly ahead of estimates.Trisura's $0.78 operating EPS beat RBC's $0.72 estimate and $0.76 consensus, notes analyst Bart Dziarski, who is maintaining an outperform rating on the company.Gross premiums written (GPW) rose 3% YoY driven by Surety (+12%), Warranty (+9%) and US Programs (+6%), offset by Canadian Fronting (down 24%) as elevated competition appears to be intensifying, he adds.Trisura also expanded its U.S. Surety practice into five new states: Illinois, Pennsylvania, Georgia, Washington, and Florida. The last remaining major state for the company to obtain a license in is California, which Dziarski expect to occur in the near-term. RBC is modelling 2026 US GPW growth of 13%, accelerating to 16% in 2027."TSU trades at a slight discount to specialty peers and we believe a premium is warranted given superior growth profile."Price: $41.49, Change: $-0.67, Percent Change: -1.59%

$TSU.TO
Mining & Metals

Aurania Resources Raising $1.5 Million Via a Non-Brokered Private Placement of Share Units

Aurania Resources (ARU.V) on Monday said will raise up to $1.5 million in a private placement of share units.The company will place up to 8.3-million units priced at $0.18 apiece and made up of a share and a two-year warrant to buy a share for $0.35.The company has reserved the right to increase the size of the offering by up to 25%, raising up to an additional $375,000.Proceeds will be primarily used for exploration at the Thor's Valley epithermal gold project in Iceland, the Balangero nickel-cobalt tailings retreatment project in Italy, and for general working capital needs.Shares of the company were last seen unchanged at $0.205 on the TSX Venture Exchange.

$ARU.V
Mining & Metals

CIBC Raises Chorus Aviation's Price Target to C$31.00 From C$30.00

CIBC Capital Markets maintained its outperformer rating on the shares of Chorus Aviation (CHR.TO) and raised its price target to C$31.00 from C$30.00 after the company reported its first-quarter financial results on May 7.The company's Q1 results were broadly in line with CIBC's expectations and continue to reinforce the durability of the company's contracted cash flow profile, noted analyst Alexander Augimeri.While parts sales revenue has been down ~30% Y/Y for two consecutive quarters, this weakness largely reflects the timing of several parts sales transactions that closed shortly after quarter end, as well as tougher comparisons against prior year periods of higher-than-typical parts activity, Augimeri said. As a result, CIBC sees a return to positive Y/Y growth in the parts sales segment beginning in Q2/26."Separately, CHR will begin to lap the previously announced wind-down of UN related flying in Q3/26," the analyst added. "Taken together, we believe the upcoming quarters should mark a transition away from recent noise in Y/Y reported results and toward a cleaner Y/Y growth profile across CHR's parts sales and contract flying segments."CIBC said, stepping back, it continues to view parts sales as a "structurally attractive business" with recurring demand characteristics and a long-term growth profile of ~5% annually, but with "inherent lumpiness" on a quarterly basis."Q2/26 will also reflect a full quarter contribution from the Kadex acquisition, which has historically grown at a 5% - 10% rate, providing incremental support to segment growth going forward," added CIBC. "For context, we had previously modeled the Kadex acquisition closing at the end of Q2/26."Price: $24.22, Change: $+1.03, Percent Change: +4.44%

$CHR.TO